Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For:	Broglio K, Walsh A. Referring patients to hospice or palliative care. Nurse Pract 2017;42:49-55. [PMID: 28306661 DOI: 10.1097/01.npr.0000511008.14090.1d] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]

Number	Cited by Other Article(s)
1	Lenahan CM, Harrington D, Stueben F. SGLT2 inhibitors: What role do they play in heart failure with reduced ejection fraction? Nurse Pract 2021;46:30-37. [PMID: 34138811 DOI: 10.1097/01.npr.0000753832.85114.65] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Abstract ABSTRACT Sodium-glucose cotransporter-2 (SGLT2) inhibitors can decrease risk for heart failure in patients with type 2 diabetes and can decrease risk of major cardiovascular events in patients with heart failure (HF) and diabetes. Specific SGLT2 inhibitors can also decrease major cardiovascular events in patients with HF only. Collapse Key Words Collapse MESH Headings Clinical Trials as Topic Heart Failure/classification Heart Failure/drug therapy Heart Failure/physiopathology Humans Referral and Consultation Sodium-Glucose Transporter 2 Inhibitors/adverse effects Sodium-Glucose Transporter 2 Inhibitors/pharmacology Sodium-Glucose Transporter 2 Inhibitors/therapeutic use Stroke Volume/drug effects Stroke Volume/physiology Treatment Outcome Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Lenahan CM, Harrington D, Stueben F. SGLT2 inhibitors: What role do they play in heart failure with reduced ejection fraction? Nurse Pract 2021;46:30-37. [PMID: 34138811 DOI: 10.1097/01.npr.0000753832.85114.65] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]